Davis Georgia M, Galindo Rodolfo J, Migdal Alexandra L, Umpierrez Guillermo E
Department of Medicine, Emory University, 69 Jesse Hill Jr Drive Southeast, Glenn Memorial Building, Suite 200, Atlanta, GA 30303, USA.
Department of Medicine, Emory University, 69 Jesse Hill Jr Drive Southeast, Glenn Memorial Building, Suite 200, Atlanta, GA 30303, USA.
Endocrinol Metab Clin North Am. 2020 Mar;49(1):79-93. doi: 10.1016/j.ecl.2019.11.002.
In past decades, a rapid evolution of diabetes technology led to increased popularity and use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in the ambulatory setting for diabetes management, and recently, the artificial pancreas became available. Efforts to translate this technology to the hospital setting have shown accuracy and reliability of CGM, safety of CSII in appropriate populations, improvement of inpatient glycemic control with computerized glycemic management systems, and feasibility of inpatient CGM-CSII closed-loop systems. Several ongoing studies are focusing on continued translation of this technology to improve glycemic control and outcomes in hospitalized patients.
在过去几十年中,糖尿病技术迅速发展,使得动态血糖监测(CGM)和持续皮下胰岛素输注(CSII)在门诊糖尿病管理中的应用越来越广泛且受到欢迎。最近,人工胰腺也已问世。将这些技术应用于医院环境的努力已证明,CGM具有准确性和可靠性,CSII在合适人群中具有安全性,计算机化血糖管理系统可改善住院患者的血糖控制,并且住院CGM-CSII闭环系统具有可行性。目前正在进行的几项研究聚焦于继续将该技术应用于改善住院患者的血糖控制及治疗效果。